VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 17 filers reported holding VANECK VECTORS ETF TR in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $284,158 | +21.8% | 10,560 | +36.3% | 0.15% | +25.4% |
| Q2 2023 | $233,309 | -3.0% | 7,749 | +4.3% | 0.12% | -4.7% |
| Q1 2023 | $240,411 | +11.1% | 7,432 | -1.6% | 0.13% | +5.8% |
| Q4 2022 | $216,485 | +1.2% | 7,554 | -3.3% | 0.12% | +0.8% |
| Q2 2022 | $214,000 | -32.9% | 7,810 | -6.2% | 0.12% | -31.0% |
| Q1 2022 | $319,000 | +29.1% | 8,326 | +7.9% | 0.17% | +24.3% |
| Q4 2021 | $247,000 | -21.3% | 7,714 | -27.7% | 0.14% | -25.5% |
| Q3 2021 | $314,000 | +20.8% | 10,666 | +39.4% | 0.19% | +15.3% |
| Q2 2021 | $260,000 | +2.0% | 7,650 | -2.5% | 0.16% | -3.0% |
| Q1 2021 | $255,000 | -7.9% | 7,850 | +2.0% | 0.17% | +58.5% |
| Q4 2020 | $277,000 | – | 7,694 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |